CompletedPhase 2

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

United Kingdom113 participantsStarted 2010-01

Plain-language summary

Cross-over study to evaluate the effect on trough FEV1 after 4 weeks treatment with CHF5188 pMDI qd in adult patients with persistent asthma

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Moderate or severe asthma partly controlled with ICS or ICS/LABA * FEV1 ≥ 60% and ≤ 90% of predicted for the patient normal value Exclusion Criteria: * Diagnosis of COPD * History or current evidence of significant cardiovascular disease * Uncontrolled concomitant disease

What they're measuring

Trough FEV1 (mean 23h-24h FEV1)

Timeframe: after day 28 dose

Trial details

NCT IDNCT01070524

SponsorChiesi Farmaceutici S.p.A.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-07

View on ClinicalTrials.gov More Asthma trials